{"id":807,"date":"2026-06-30T10:00:24","date_gmt":"2026-06-30T10:00:24","guid":{"rendered":"https:\/\/fecundis.com\/?p=807"},"modified":"2026-07-22T15:08:35","modified_gmt":"2026-07-22T15:08:35","slug":"hypersperm-clinical-study-ivf-embryo-quality","status":"publish","type":"post","link":"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/","title":{"rendered":"Nueva evidencia cl\u00ednica demuestra que HyperSperm\u2122 mejora la producci\u00f3n de blastocistos y la calidad embrionaria en ciclos de FIV"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Fecundis ha alcanzado un hito cient\u00edfico importante con la publicaci\u00f3n de un nuevo estudio cl\u00ednico en la revista <\/span><i><span style=\"font-weight: 400;\">Journal of Translational Medicine<\/span><\/i><span style=\"font-weight: 400;\">, que demuestra que HyperSperm\u2122 mejora resultados clave del desarrollo embrionario en parejas sometidas a fecundaci\u00f3n in vitro.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El estudio prospectivo multic\u00e9ntrico, realizado en Argentina en colaboraci\u00f3n con 3 cl\u00ednicas de fertilidad \u2014Pregna Medicina Reproductiva, Fertya Medicina Reproductiva e In Vitro Buenos Aires\u2014 evalu\u00f3 el efecto de HyperSperm en 41 pacientes de FIV utilizando un dise\u00f1o de ovocitos hermanos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Este tipo de estudio es particularmente relevante en reproducci\u00f3n asistida porque los ovocitos de una misma paciente se dividen en dos grupos. En este caso, una parte de los ovocitos fue inseminada con espermatozoides preparados mediante procedimientos est\u00e1ndar de laboratorio, mientras que la otra parte fue inseminada con espermatozoides preparados mediante el protocolo HyperSperm. Este dise\u00f1o ayuda a reducir la variabilidad entre pacientes y permite una comparaci\u00f3n m\u00e1s directa entre ambos enfoques de preparaci\u00f3n esperm\u00e1tica.<\/span><\/p>\n<h2><b>\u00bfPor qu\u00e9 la preparaci\u00f3n esperm\u00e1tica es importante en la FIV?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">En reproducci\u00f3n asistida, la evaluaci\u00f3n esperm\u00e1tica se ha centrado tradicionalmente en la concentraci\u00f3n, la motilidad y la morfolog\u00eda. Estos par\u00e1metros son esenciales, pero no describen completamente si un espermatozoide est\u00e1 funcionalmente preparado para fecundar el ovocito y sustentar el desarrollo embrionario.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Antes de que ocurra la fecundaci\u00f3n de forma natural, los espermatozoides atraviesan un proceso biol\u00f3gico complejo conocido como capacitaci\u00f3n. Durante este proceso, adquieren la competencia funcional necesaria para interactuar con el ovocito. Sin embargo, los m\u00e9todos convencionales de preparaci\u00f3n esperm\u00e1tica en FIV se centran principalmente en recuperar espermatozoides m\u00f3viles y no reproducen completamente el entorno din\u00e1mico del tracto reproductor femenino.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">HyperSperm se desarroll\u00f3 para solucionar este problema. En lugar de limitarse a seleccionar espermatozoides, esta tecnolog\u00eda est\u00e1 dise\u00f1ada para optimizar su funci\u00f3n recreando etapas clave de la capacitaci\u00f3n previa a la fecundaci\u00f3n.<\/span><\/p>\n<h2><b>Principales hallazgos del estudio cl\u00ednico<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">HyperSperm aument\u00f3 el desarrollo de blastocistos en comparaci\u00f3n con la preparaci\u00f3n esperm\u00e1tica est\u00e1ndar.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Los principales resultados incluyeron:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mayor tasa de desarrollo a blastocisto: 55,6% con HyperSperm frente a 47,9% con la preparaci\u00f3n est\u00e1ndar.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mayor tasa de blastocistos utilizables: 48,9% con HyperSperm frente a 40,1% con la preparaci\u00f3n est\u00e1ndar.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">En 5 casos en los que el grupo de control no produjo blastocistos, el grupo tratado con HyperSperm gener\u00f3 al menos un blastocisto utilizable.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">En el subgrupo de embriones analizados mediante PGT-A, se observ\u00f3 una mayor proporci\u00f3n de embriones euploides en el grupo HyperSperm.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Hasta la fecha, han nacido 11 beb\u00e9s tras el uso de HyperSperm, sin anomal\u00edas reportadas, lo que refuerza el perfil de seguridad observado hasta el momento.\u00a0<\/span><\/p>\n<h2><b>M\u00e1s embriones, m\u00e1s opciones cl\u00ednicas<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">En FIV, cada blastocisto viable importa. Un mayor n\u00famero de embriones con potencial de transferencia o criopreservaci\u00f3n puede ampliar las opciones cl\u00ednicas disponibles dentro de un mismo ciclo de tratamiento.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Esto es especialmente relevante para pacientes que obtienen pocos embriones o que, de otro modo, podr\u00edan finalizar un ciclo sin ning\u00fan blastocisto transferible. En este contexto, mejorar la preparaci\u00f3n esperm\u00e1tica antes de la fecundaci\u00f3n podr\u00eda tener un impacto relevante en la eficiencia de los flujos de trabajo en FIV y en el n\u00famero de oportunidades disponibles para los pacientes.<\/span><\/p>\n<h2><b>Un cambio central: la optimizaci\u00f3n de los espermatozoides<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">La publicaci\u00f3n de este estudio refuerza el enfoque cient\u00edfico de Fecundis: ir m\u00e1s all\u00e1 de la recuperaci\u00f3n convencional de espermatozoides y avanzar hacia la optimizaci\u00f3n de la funci\u00f3n esperm\u00e1tica.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Mientras muchas tecnolog\u00edas de preparaci\u00f3n esperm\u00e1tica se centran en seleccionar los mejores espermatozoides de una muestra, HyperSperm se basa en un concepto diferente: apoyar los procesos biol\u00f3gicos que los espermatozoides necesitan para adquirir competencia funcional antes de la fecundaci\u00f3n.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Estos hallazgos se suman a la creciente evidencia de que la fisiolog\u00eda esperm\u00e1tica desempe\u00f1a un papel activo en el desarrollo embrionario temprano. Tambi\u00e9n apoyan la idea de que la biolog\u00eda esperm\u00e1tica avanzada puede convertirse en un importante motor de innovaci\u00f3n en los laboratorios de FIV.<\/span><\/p>\n<p>Para Fecundis, esta publicaci\u00f3n refuerza un compromiso central: acercar la biotecnolog\u00eda basada en ciencia a las necesidades reales de los laboratorios de FIV y de los pacientes. A trav\u00e9s de una mejor comprensi\u00f3n y apoyo de la funci\u00f3n esperm\u00e1tica, nuestro objetivo es contribuir a mejorar el desarrollo embrionario y ampliar las opciones cl\u00ednicas disponibles para los pacientes.<\/p>\n<h2><b>Referencia<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Oscoz-Susino N. et al. <\/span><i><span style=\"font-weight: 400;\">A multicenter, prospective sibling oocyte study revealed that HyperSperm\u2122 improves the number and quality of embryos in patients undergoing in vitro fertilization<\/span><\/i><span style=\"font-weight: 400;\">. Journal of Translational Medicine. 2026.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Fuente: <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08261-4\">https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08261-4<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Un nuevo estudio cl\u00ednico multic\u00e9ntrico publicado en la revista Journal of Translational Medicine demuestra que HyperSperm mejora la producci\u00f3n de blastocistos y la calidad embrionaria en ciclos de FIV.<\/p>","protected":false},"author":3,"featured_media":828,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[10],"class_list":["post-807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science","tag-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HyperSperm Clinical Study Shows Improved Embryo Quality in IVF<\/title>\n<meta name=\"description\" content=\"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF\" \/>\n<meta property=\"og:description\" content=\"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/\" \/>\n<meta property=\"og:site_name\" content=\"Fecundis\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T10:00:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-22T15:08:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3.-TEAM-PAPER-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fran Lobbosco\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fran Lobbosco\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\"},\"author\":{\"name\":\"Fran Lobbosco\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/person\\\/f41edd2dcd27cb93d795a45ebf475667\"},\"headline\":\"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF\",\"datePublished\":\"2026-06-30T10:00:24+00:00\",\"dateModified\":\"2026-07-22T15:08:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\"},\"wordCount\":638,\"publisher\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3.-TEAM-PAPER-scaled.jpg\",\"keywords\":[\"Article\"],\"articleSection\":[\"Science\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\",\"url\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\",\"name\":\"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3.-TEAM-PAPER-scaled.jpg\",\"datePublished\":\"2026-06-30T10:00:24+00:00\",\"dateModified\":\"2026-07-22T15:08:35+00:00\",\"description\":\"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3.-TEAM-PAPER-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3.-TEAM-PAPER-scaled.jpg\",\"width\":2560,\"height\":1733},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fecundis.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#website\",\"url\":\"https:\\\/\\\/fecundis.com\\\/\",\"name\":\"Fecundis\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fecundis.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#organization\",\"name\":\"Fecundis\",\"url\":\"https:\\\/\\\/fecundis.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/fecundis-logo.svg\",\"contentUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/fecundis-logo.svg\",\"width\":580,\"height\":153,\"caption\":\"Fecundis\"},\"image\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/fecundis-lab\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/person\\\/f41edd2dcd27cb93d795a45ebf475667\",\"name\":\"Fran Lobbosco\",\"url\":\"https:\\\/\\\/fecundis.com\\\/es\\\/author\\\/fran\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF","description":"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/","og_locale":"es_ES","og_type":"article","og_title":"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF","og_description":"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.","og_url":"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/","og_site_name":"Fecundis","article_published_time":"2026-06-30T10:00:24+00:00","article_modified_time":"2026-07-22T15:08:35+00:00","og_image":[{"width":2560,"height":1733,"url":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3.-TEAM-PAPER-scaled.jpg","type":"image\/jpeg"}],"author":"Fran Lobbosco","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Fran Lobbosco","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#article","isPartOf":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/"},"author":{"name":"Fran Lobbosco","@id":"https:\/\/fecundis.com\/#\/schema\/person\/f41edd2dcd27cb93d795a45ebf475667"},"headline":"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF","datePublished":"2026-06-30T10:00:24+00:00","dateModified":"2026-07-22T15:08:35+00:00","mainEntityOfPage":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/"},"wordCount":638,"publisher":{"@id":"https:\/\/fecundis.com\/#organization"},"image":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3.-TEAM-PAPER-scaled.jpg","keywords":["Article"],"articleSection":["Science"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/","url":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/","name":"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF","isPartOf":{"@id":"https:\/\/fecundis.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage"},"image":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3.-TEAM-PAPER-scaled.jpg","datePublished":"2026-06-30T10:00:24+00:00","dateModified":"2026-07-22T15:08:35+00:00","description":"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.","breadcrumb":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage","url":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3.-TEAM-PAPER-scaled.jpg","contentUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3.-TEAM-PAPER-scaled.jpg","width":2560,"height":1733},{"@type":"BreadcrumbList","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fecundis.com\/"},{"@type":"ListItem","position":2,"name":"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF"}]},{"@type":"WebSite","@id":"https:\/\/fecundis.com\/#website","url":"https:\/\/fecundis.com\/","name":"Fecundis","description":"","publisher":{"@id":"https:\/\/fecundis.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fecundis.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/fecundis.com\/#organization","name":"Fecundis","url":"https:\/\/fecundis.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fecundis.com\/#\/schema\/logo\/image\/","url":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/04\/fecundis-logo.svg","contentUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/04\/fecundis-logo.svg","width":580,"height":153,"caption":"Fecundis"},"image":{"@id":"https:\/\/fecundis.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/fecundis-lab\/"]},{"@type":"Person","@id":"https:\/\/fecundis.com\/#\/schema\/person\/f41edd2dcd27cb93d795a45ebf475667","name":"Fran Lobbosco","url":"https:\/\/fecundis.com\/es\/author\/fran\/"}]}},"_links":{"self":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts\/807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/comments?post=807"}],"version-history":[{"count":6,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts\/807\/revisions"}],"predecessor-version":[{"id":825,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts\/807\/revisions\/825"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/media\/828"}],"wp:attachment":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/media?parent=807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/categories?post=807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/tags?post=807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}